Clinical Trials Directory

Trials / Completed

CompletedNCT02181244

Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects

Egg Effects on Atherogenic Dyslipidemia, Glucose Metabolism and Inflammation in Diabetic Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
University of Connecticut · Academic / Other
Sex
All
Age
35 Years – 65 Years
Healthy volunteers
Not accepted

Summary

There is concern in the literature regarding egg consumption in diabetic people. The investigators hypothesis is that compared to an oatmeal-based breakfast, an egg-based breakfast will not increase the risk for heart disease in diabetic people but it may reduce inflammation, in this population characterized by chronic low grade inflammation. This is a cross-over study in which subjects will be randomly allocated to consume 1 egg per day for breakfast or a bowl of oatmeal with lactose-free milk for 5 weeks. After a 3 wk washout period, subjects will be allocated to the alternate treatment for additional 5 weeks. Blood will be collected at baseline and at the end of each dietary period to measure plasma lipids, glucose, insulin, glycosylated hemoglobin and inflammatory markers.

Detailed description

This study is conducted in diabetic patients who are given two distinct breakfasts: eggs and oatmeal in a crossover design. The investigators hypothesis is that eggs will not increase the risk for heart disease in this population when compared to oatmeal but they will more likely reduce inflammation due to the presence of the carotenoids, lutein and zeaxanthin that are highly available in eggs. In this study, the investigators are evaluating three main things * Atherogenic dyslipidemia by measuring plasma lipids and lipoprotein mean size and subfractions by nuclear magnetic resonance. * Glucose metabolism by measuring plasma glucose, insulin, insulin resistance and glycosylated hemoglobin. * Inflammation by measuring liver enzymes, C reactive protein, tumor necrosis factor-alpha, interleukin-6. All these measurements were done 24 weeks after completion of the study All data will be presented 1 year after completion of the study

Conditions

Interventions

TypeNameDescription
OTHEREgg, one a day, for breakfastOne egg per day as breakfast for 5 weeks followed by a 3 week washout period and 5 additional weeks on oatmeal. This is a randomized crossover design. Half of subjects started with the eggs and the other half with oatmeal. Blood lipids, glucose and inflammatory measurements will be finished 24. weeks after completion of the study. Data will be reported 1 year after the completion of the study.
OTHEROatmeal, one cup a daySubjects will be fed oatmeal for a period of 5 weeks. After 3 weeks they will be switched to the alternate diet. This is a randomized control trail in which plasma glucose, plasma lipids and inflammatory markers will be measured. All these measurements will be finished 24 weeks after completion of the study. Data will be reported after 1 year of the completion of the study.

Timeline

Start date
2013-05-01
Primary completion
2014-01-01
Completion
2014-06-01
First posted
2014-07-03
Last updated
2014-07-03

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT02181244. Inclusion in this directory is not an endorsement.